Advertisement

Heart Transplantation

  • Herwig Antretter
  • Guenther Laufer
  • Janet E. Kuhlman
Chapter
  • 885 Downloads
Part of the Medical Radiology book series (MEDRAD)

Abstract

Heart transplantation (HTX) has evolved over the past 39 years from a rarely performed experimental procedure to a clinically well established therapy with an excellent circumoperative outcome regarding survival and quality of life. It was Christiaan Barnard who performed unexpectedly the first successfulhuman-to-humanhearttransplant(allograft) on 3 December, 1967 at Groote Schuur Hospital in Cape Town, South Africa (Barnard 1967, 1968); however, outstanding efforts to develop this surgical therapy were made by Norman Shumway and Richard Lower at Stanford University (Lower and Shumway 1960; Shumway et al. 1966) overalongperiod of time. Norman Shumway himself performed the fourth heart transplant in the world in January 1968, which was the first adult human to human heart transplantation in the United States.

Keywords

Heart Transplantation Superior Vena Cava Left Ventricular Assist Device Hypoplastic Left Heart Syndrome Cardiac Allograft 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aaronson KD, Schwartz JS, Chen T-M et al (1997) Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 95:2660–2667PubMedGoogle Scholar
  2. Angermann EC, Spes CH, Tammen A et al (1990) Anatomic characteristics and valvular function of the transplanted heart: transthoracic versus transesophageal echocardiographic findings. J Heart Transplant 9:331–338PubMedGoogle Scholar
  3. Antretter H, Hangler H, Hoefer D et al (2002a) Totaler und partieller Herzersatz Trends und Entwicklungen. J Kardiol 9:3–13Google Scholar
  4. Antretter H, Poelzl G, Margreiter J et al (2002b) Successful transfer of a cardiac allograft from a heterotopic to an orthotopic position 16 years after heart transplantation. Transplantation 74:540–543PubMedGoogle Scholar
  5. Antretter H, Hoefer D, Hangler H et al (2004) Long-term outcome of cytomegalovirus high risk patients after heart transplantation: comparison between two prophylactic regimes —a single center experience. Eur Surg 36:113–120Google Scholar
  6. Aull MJ, Buell JF, Trofe J et al (2004) Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry. Transplantation 78:1676–1682PubMedGoogle Scholar
  7. Bailey LL (2000) Current opinion in heart transplantation: an introduction: editorial commentary. Curr Opin Organ Transplant 5:115–117Google Scholar
  8. Bailey LL, Nehlsen-Canarella SL, Consepcion W et al (1985) Baboon-to-human cardiac xenotransplantation in a neonate. J Am Med Assoc 254:3321–3329Google Scholar
  9. Bailey LL, Gundry SR, Razzouk AJ et al (1993) Bless the babies: one hundred fifteen late survivors of heart transplantation during the first year of life. The Loma Linda University Pediatrie Heart Transplant Group. J Thorac Cardiovasc Surg 105:805–814PubMedGoogle Scholar
  10. Bailey LL, Zuppan CW, Chinnock RE et al (1995) Graft vasculopathy among recipients of heart transplantation during the first 12 years of life. The pediatric heart transplant group. Transplant Proc 27:1921–1925PubMedGoogle Scholar
  11. Barnard CN (1967) The operation. South African Med J 41:1271–1274Google Scholar
  12. Barnard CN (1968) Human cardiac transplantation: an evaluation of the first two operations performed at the Groote Schuur Hospital, Cape Town. Am J Cardiol 22:791–803Google Scholar
  13. Batista RJV, Santos JLV, Takeshita N et al (1996) Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J Cardiac Surg 11:96–97Google Scholar
  14. Billingham ME (1985) Endomyocardial biopsy detection of acute rejection in cardiac allograft recipients. Heart Vessels Suppl 1:86–90PubMedGoogle Scholar
  15. Billingham ME, Cary NRB, Hammond ME et al (1990) A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection. J Heart Lung Transplant 9:587–593Google Scholar
  16. Blanche C, Takkenberg JJM, Nessim S et al (1996) Heart transplantation in patients 65 years of age and older: a comparative analysis of 40 patients. Ann Thorac Surg 62:1442–1447PubMedGoogle Scholar
  17. Bonatti H, Tabarelli W, Ruttmann E et al (2004) Impact of cytomegalovirus match on survival after cardiac and lung transplantation. Am Surg 70:710–714PubMedGoogle Scholar
  18. Bonatti H, Hoefer D, Rogatsch H et al (2005) Successful management of recurrent Epstein-Barr virus-associated multilocular leiomyosarcoma after cardiac transplantation. Transplant Proc 37:1839–1844PubMedGoogle Scholar
  19. Boucek MM, Mathis CM, Kanakriyeh MS et al (1993) Donor shortage: use of the dysfunctional donor heart. J Heart Lung Transplant 12:186–190Google Scholar
  20. Boucek MM, Faro A, Novick RJ et al (1999) The registry of the International Society for Heart and Lung Transplantation: third official pediatric report —1999. J Heart Lung Transplant 18:1151–1172PubMedGoogle Scholar
  21. Brown ME, Sarris GE, Oyer PE (1996) Cardiac donor evaluation, retrieval, and matching to recipient. In Smith JA, MacCarthy PM, Sarris GE, Stinson EB, Reitz BA (eds) The Stanford manual of cardiopulmonary transplantation. Futura, Armonk, pp 15–30Google Scholar
  22. Calne RY (1979) Immunosuppression for organ grafting observations on cyclosporin A. Immunolog Rev 46:113–124Google Scholar
  23. Cantin B, Gao SZ, Kwok BWK et al (2002) Prognosis of patients with significant angiographically diagnosed cardiac allograft coronary disease. J Heart Lung Transplant 21:96Google Scholar
  24. Caves PK, Billingham ME, Stinson EB et al (1974) Serial transvenous biopsy of the transplanted human heart. Improved management of acute rejection episodes. Lancet 1:821–826Google Scholar
  25. Collins EG, Mozdzierz GJ (1993) Cardiac retransplantation: determining limits. Heart Lung 22:206–212PubMedGoogle Scholar
  26. Copeland JG (1995) Only optimal donors should be accepted for heart transplantation: protagonist. J Heart Lung Transplant 14:1038–1043PubMedGoogle Scholar
  27. Cooper DKC, Taniguchi S (1996) Heterotopic heart transplantation indications, surgical techniques and special considerations. In: Cooper DKC, Miller LW, Patterson GA (eds) The transplantation and replacement of thoracic organs. Kluwer, Dordrecht, pp 353–365Google Scholar
  28. Deleuze PH, Benvenuti C, Mazzuccotelli JP et al (1995) Orthotopic cardiac transplantation with direct caval anastomosis: is it the optimal procedure? J Thorac Cardiovasc Surg 109:731–737PubMedGoogle Scholar
  29. Derumeaux G, Habib G, Schleifer DM et al (1995) Standard orthotopic heart transplantation versus total orthotopic heart transplantation. A transesophageal echocardiography study of the incidence of left atrial thrombosis. Circulation 9211:196–201Google Scholar
  30. Dichtl W, Vogel W, Dunst KM et al (2005) Cardiac hepatopathy before and after heart transplantation. Transplant Int 18:697–702Google Scholar
  31. DiSalvo T, Naftel D, Kasper EK et al (1998) The differing hazard of lymphoma vs. other malignancies in the current era ⊕ multi institutional study [abstract], J Heart Lung Transplant 17:70Google Scholar
  32. Doval HC, Nul DR, Grancelli HO et al (1996) Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death. Circulation 94:3198–3203PubMedGoogle Scholar
  33. Dreyfus G, Jebara V, Mihaileanu S et al (1991) Total orthotopic heart transplantation: an alternative to standard technique. Ann Thorac Surg 52:1181–1184PubMedGoogle Scholar
  34. Dubin AM, Berul CI, Bevilacqua LM et al (2003) The use of implantable cardioverter-defibrillators in pediat ric patients awaiting heart transplantation. J Card Fail 9:375–379PubMedGoogle Scholar
  35. Dyke CM, Yeh T, Lehman JD et al (1991) Triiodothyronineenhanced left ventricular function after ischemic injury. Ann Thorac Surg 52:14–19PubMedGoogle Scholar
  36. Eisen HJ (2004) Pathogenesis and management of cardiac allograft vasculopathy. Curr Opin Organ Transplant 9:448–452Google Scholar
  37. Eisen H, Kobashigawa J, Starling RC (2005) Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors. Transplant Proc 37 [Suppl. 4S]:4–17Google Scholar
  38. Gradman AH, Deedwania PC (1994) Predictors of mortality in patients with heart failure. Cardiol Clin 12:25–35PubMedGoogle Scholar
  39. Gray J, Wreghitt TG, Pavel P et al (1995) Ebstein-Barr virus infection in heart and heart/lung transplant recipients: incidence and clinical impact. J Heart Lung Transplant 14:640PubMedGoogle Scholar
  40. Greene M, Newman D, Geist M et al (2000) Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. Europace 2:263–269Google Scholar
  41. Griffith BP, Kormos RL, Nastala CJ et al (1996) Results of extended bridge to transplantation: window into the future of permanent ventricular assist devices. Ann Thorac Surg 61:359–365Google Scholar
  42. Groetzner J, Reichart B, Roemer U et al (2005) Results of pediatric cardiac transplantation —long-term results of a 15-year experience. Thorac Cardiovasc Surg 53 [Suppl 2]:149–154Google Scholar
  43. Hankins S, Mancini DM (2001) Listing and treatment of status 1 patients. Curr Opin Organ Transplant 6:216–221Google Scholar
  44. Hathout EB, Chinnock RE (2004) Growth after heart transplantation [Editorial], Pediatr Transplant 8:97–100PubMedGoogle Scholar
  45. Hetzer R, Loebe M, Potapov EV et al (1998) Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children. Ann Thorac Surg 66:1498–1506PubMedGoogle Scholar
  46. Höfer D, Bonatti H, Poelzl G et al (2005) Cecal perforation as a rare initial manifestation of posttransplant lymphoproliferative disorder after cardiac transplantation. J Heart Lung Transplant 24:505–506Google Scholar
  47. Hosenpud JD, Bennett LE, Keck BM et al. (1997) The registry of the International Society for Heart and Lung Transplantation: fourteenth official report —1997. J Heart Lung Transplant 16: 691–712PubMedGoogle Scholar
  48. Hosenpud JD, Bennett LE, Keck BM et al (1999) The registry of the International Society for Heart and Lung Transplantation: sixteenth official report —1999. J Heart Lung Transplant 18:611–626PubMedGoogle Scholar
  49. Hosenpud JD, Bennett LE, Keck BM et al (2000) The registry of the International Society for Heart and Lung Transplantation: seventeenth official report —2000. J Heart Lung Transplant 19:909–931PubMedGoogle Scholar
  50. Iberer F, Grasser B, Schreier G et al (1998) Introducing a new clinical method for noninvasive rejection monitoring after heart transplantation to clinical practice: analysis of paced intramyocardial electrograms. Transplant Proc 30:895–899PubMedGoogle Scholar
  51. Ikonen TS, Gummert JF, Hayase M et al (2000) Sirolimus (rapamycin) halts and reverses progression of allograft vascular disease in non-human primates. Transplantation 70:1773–1780Google Scholar
  52. Jamieson SW, Burton NA, Bieber CP et al (1979) Cardiac-allograft survival in primates treated with cyclosporin A. Lancet 10:545Google Scholar
  53. John R, Chen JM, Weinber A et al (1999) Long-term survival after cardiac retransplantation: a twenty-year single-center experience. J Thorac Cardiovasc Surg 117:543–555PubMedGoogle Scholar
  54. Kirklin JW, Barratt-Boyes BG (1993) Primary cardiomyopathy and cardiac transplantation. In: Kirklin JW, BarrattBoyes BG (eds) Cardiac surgery. Churchill Livingstone, New York, pp 1655–1681Google Scholar
  55. Kirklin JK, Young JB, McGiffin DC (2002a) Recipient evaluation and selection. In: Kirklin JK, Young JB, McGiffin DC (eds) Heart transplantation. Churchill Livingstone, New York, pp 198–231Google Scholar
  56. Kirklin JK, Young JB, McGiffin DC (2002b) The donor heart. In: Kirklin JK, Young JB, McGiffin DC (eds) Heart transplantation. Churchill Livingstone, New York, pp 293–338Google Scholar
  57. Kirklin JK, Young JB, McGiffin DC (2002c) The heart transplant operation. In: Kirklin JK, Young JB, McGiffin DC (eds) Heart transplantation. Churchill Livingstone, New York, pp 339–352Google Scholar
  58. Kirklin JK, Young JB, McGiffin DC (2002d) Physiology of the transplanted heart. In: Kirklin JK, Young JB, McGiffin DC (eds) Heart transplantation. Churchill Livingstone, New York, pp 353–372Google Scholar
  59. Kirklin JK, Young JB, McGiffin DC (2002e) Cardiac allograft rejection. In: Kirklin JK, Young JB, McGiffin DC (eds) Heart transplantation. Churchill Livingstone, New York, pp 464–520Google Scholar
  60. Klima U, Ringes-Lichtenberg S, Warnecke G et al (2005) Severe right heart failure after heart transplantation. A single-center experience. Transplant Int 18:326–332Google Scholar
  61. Kobashigawa J, Miller L, Renlund D et al (1998) A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate mofetil investigators. Transplantation 66:507–515PubMedGoogle Scholar
  62. König A, Theisen K, Klauss V (2000) Intravascular ultrasound for assessment of coronary allograft vasculopathy. Z Kardiol 89 [Suppl 9]:45–49Google Scholar
  63. Laks H (1995) Only optimal donors should be accepted for heart transplantation: antagonist. J Heart Lung Transplant 14:1043–1046PubMedGoogle Scholar
  64. Libby P (1996) Transplantation associated arteriosclerosis: potential mechanisms. In: Tilney N, Storm T, Paul L (eds) Transplantation biology: cellular and molecular aspects. Lippincott-Raven, Philadelphia, pp 577–586Google Scholar
  65. Lietz K, John R, Mancini DM et al (2004) Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list. J Am Coll Cardiol 4:1553–1561Google Scholar
  66. Linde C, Braunschweig F, Gadler F et al (2003) Long-term improvements in quality of life by biventricular pacing in patients with chronic heart failure: results from the multisite stimulation in cardiomyopathy study (MUSTIC). Am J Cardiol 91:1090–1095PubMedGoogle Scholar
  67. Losman JG, Barnard CN (1977) Hemodynamic evaluation of left ventricular bypass with a homologous cardiac graft. J Thorac Cardiovasc Surg 74:695–708PubMedGoogle Scholar
  68. Lower RR, Shumway NE (1960) Studies on orthotopic transplantation of the canine heart. Surgical Forum 11:18–19PubMedGoogle Scholar
  69. Magovern GJ, Simpson KA (1996) Clinical cardiomyoplasty: review of the ten-year United States experience. Ann Thorac Surg 61:413–419PubMedGoogle Scholar
  70. Mancini DM, Eisen H, Kussmaul W et al (1991) Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83:778–786PubMedGoogle Scholar
  71. Marelli D, Laks H, Kobashigawa JA et al (2002) Seventeenyear experience with 1,083 heart transplants at a single institution. Ann Thorac Surg 74:1558–1566PubMedGoogle Scholar
  72. McCarthy PM, Smith JA, Siegel LC et al (1996) Cardiac transplant admission, anesthesia and operative procedures. In: Smith JA, MacCarthy PM, Sarris GE, Stinson EB, Reitz BA (eds) The Stanford manual of cardiopulmonary transplantation. Futura, Armonk, pp 31–61Google Scholar
  73. McCarthy PM, Starling RC, Wong J et al (1997) Early results with partial left ventriculectomy. J Thorac Cardiovasc Surg 114:755–763PubMedGoogle Scholar
  74. Melton IC, Gilligan DM, Wood MA et al (1999) Optimal cardiac pacing after heart transplantation. PACE 22:1510–1527PubMedGoogle Scholar
  75. Meyer SR, Modry DL, Bainey K et al (2005) Declining need for permanent pacemaker insertion with the bicaval technique of orthotopic heart transplantation. Can J Cardiol 21:159–163PubMedGoogle Scholar
  76. Miniati DN, Robbin RC (2002) Heart transplantation: a thirty-year perspective. Annu Rev Med 53:189–205PubMedGoogle Scholar
  77. Mohanty PK, Thomas MD, Arrowood JA et al (1987) Impairment of cardiopulmonary baroreflex after cardiac transplantation in humans. Circulation 75:21Google Scholar
  78. Moreira LFP, Stolf NAG, Braile DM et al (1996) Dynamic cardiomyoplasty in South America. Ann Thorac Surg 61:413–419Google Scholar
  79. Morgan JA, Edwards NM (2005) Orthotopic cardiac transplantation: comparison of outcome using biatrial, bicaval, and total techniques. J Card Surg 20:102–106PubMedGoogle Scholar
  80. Müller J, Warnecke H, Spiegelsberger S et al (1993) Reliable noninvasive rejection diagnosis after heart transplantation in childhood. J Heart Lung Transplant 12:189–198PubMedGoogle Scholar
  81. Newcomb AE, Esmore DS, Rosenfeldt FL et al (2004) Heterotopic heart transplantation: an expanding role in the twenty-first century? Ann Thorac Surg 78:1345–1351PubMedGoogle Scholar
  82. Novitzky D, Cooper DKC, Reichart B (1987) Hemodynamic and metabolic responses to hormonal therapy in braindead potential organ donors. Transplantation 43:852–854PubMedGoogle Scholar
  83. Penn I (1993) Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 12:328–336Google Scholar
  84. Poelzl G, Ullrich R, Huber A et al (2005) Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy. Transplant Int 18:313–317Google Scholar
  85. Poston RS, Griffith BP (2004) Heart transplantation. J Intensive Care Med 19:3–12PubMedGoogle Scholar
  86. Razzouk AJ (2000) Cardiac retransplantation. Curr Opin Organ Transplant 5:154–157Google Scholar
  87. Razzouk AJ, Chinnock RE, Gundry SR et al (1996) Transplantation as primary treatment for hypoplastic left heart syndrome: intermediate-term results. Ann Thorac Surg 62:1–8PubMedGoogle Scholar
  88. Razzouk AJ, Chinnock RE, Dearani JA et al (1998) Cardiac retransplantation for graft vasculopathy in children: should we continue to do it ? Arch Surg 133:881–885PubMedGoogle Scholar
  89. Renlund DG (2004) Building a bridge to heart transplantation. N Engl J Med 351:849–851PubMedGoogle Scholar
  90. Scheule AM, Zimmermann GJ, Johnston JK et al (2002) Duration of graft cold ischemia does not affect outcomes in pediatric heart transplant recipients. Circulation 106:163–167Google Scholar
  91. Schmid C, Tjan TDT, Scheid HH (2005) Techniques of pediatric heart transplantation. Thoracic Cardiovasc Surg 53 [Suppl 2]:141–145Google Scholar
  92. Schnetzler B, Pavie A, Dorent R et al (1998) Heart retransplantation: a 23-year single-center clinical experience. Ann Thorac Surg 65:978–983PubMedGoogle Scholar
  93. Segovia J (2002) Update on cardiac allograft vasculopathy. Curr Opin Organ Transplant 7:240–251Google Scholar
  94. Shumway NE, Lower RR, Stofer RC (1966) Transplantation of the heart. Adv Surg 2:265–284PubMedGoogle Scholar
  95. Stark RP, McGinn AL, Wilson RF (1991) Chest pain in cardiac transplant recipients. Evidence of sensory reinnervation after cardiac transplantation. N Engl J Med 324:1791–1794PubMedGoogle Scholar
  96. Starnes VA, Bernstein D, Oyer PE et al (1989) Heart transplantation in children. J Heart Transplant 8:20–26PubMedGoogle Scholar
  97. Stevenson LW, Tillisch TH, Hamilton M et al (1990) Importance of hemodynamic response to therapy in predicting survival with ejection fraction <20% secondary to ischemie or nonischemic dilated cardiomyopathy. Am J Cardiol 66:1348–1354PubMedGoogle Scholar
  98. Taylor DO, Barr ML, Radovancevic B et al (1999) A randomised, multicenter comparison of TAC and CsA immunosuppressive regimes in cardiac transplantation: decreased hyperlipidemia and hypertension with TAC. J Heart Lung Transplant 18:336Google Scholar
  99. Taylor DO, Edwards LB, Boucek MM et al (2004) The registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report 2004. J Heart Lung Transplant 23:796–803PubMedGoogle Scholar
  100. Tuzku EM, Schoenhagen P, Starling RC et al (2002) Impact of everolimus on allograft vasculopathy: the SDZ RAD/heart intravascular ultrasound study. J Heart Lung Transplant 21:68Google Scholar
  101. Warnecke H, Müller J, Cohnert T et al (1992) Clinical heart transplantation without routine endomyocardial biopsy. J Heart Lung Transplant 11:1093–1102PubMedGoogle Scholar
  102. Watson DC, Reitz BA, Baumgartner WA et al (1979) Distant heart procurement for transplantation. Surgery 86:56–59PubMedGoogle Scholar
  103. Wheeldon DR, Potter CDO, Oduro A et al (1995) Transforming the “unacceptable”donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 14:734–742PubMedGoogle Scholar
  104. Yacoub M, Mankad P, Ledingham S (1990) Donor procurement and surgical techniques for cardiac transplantation. Semin Thorac Cardiovasc Surg 2:153–161PubMedGoogle Scholar
  105. Yun JJ, Fischbein MP, Laks H et al (2001) Chronic rejection of transplanted hearts. Curr Opin Organ Transplant 6:205–210Google Scholar

References

  1. Almenar L, Igual B, Martinez-Dolz L, Arnau MA, Osa A, Rrueda J, Palencia M (2003) Utility of cardiac magnetic resonance imaging for the diagnosis of heart transplant rejection. Transplant Proc 35:1962–1964PubMedGoogle Scholar
  2. Armitage JM, Kormos RL, Stuart RS et al (1991) Post-transplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 10:877–886PubMedGoogle Scholar
  3. Austin JH, Schulman LL, Mastrobattista JD (1989) Pulmonary infection after cardiac transplantation: clinical and radiologie correlations. Radiology 172:259–265PubMedGoogle Scholar
  4. Bae KT, Hong C, Takahashi N, Gutierrez F, Shakey A, Hirsch R, Canter CE (2004) Multi-detector row computed tomographic angiography in pediatric heart transplant recipients: initial observations. Transplantation 77(4):599–602PubMedGoogle Scholar
  5. Bagan P, Assouad J, Berna P, Souilamas R, Barthes F, Riquet M (2005) Immediate and long-term survival after surgery for lung cancer in heart transplant recipients. Ann Thorac Surg 79:438–442PubMedGoogle Scholar
  6. Barbir M, Bowker T, Ludman PF, Mitchell AG, Wood D, Yacoub M (1994) Ultrafast computed tomographic scanning for detection of coronary disease in cardiac transplant recipients. Am J Cardiol 74:941–944PubMedGoogle Scholar
  7. Billingham ME (1989) Graft coronary disease: the lesion and the patients. Transplant Proc 21:3665–3666PubMedGoogle Scholar
  8. Bnakier AA, Muylem AV, Scillia P, De Maertelaer V, Estenne M, Genevois PA (2003) Air trapping in heart-lung transplant recipients: variability of anatomic distribution and extent at sequential expiratory thin-section CT. Radiology 229:737–742Google Scholar
  9. Delcambre F, Pruvot FR, Ramon P et al (1996) Primary bronchogenic carcinoma in transplant recipients. Transplant Proc 28:2884–2885PubMedGoogle Scholar
  10. Gao SZ, Schroeder JS, Alderman EL et al (1989) Prevalence of accelerated coronary artery disease in heart transplant survivors: comparison of cyclosporine and azathioprine regimens. Circulation 80:100–105Google Scholar
  11. Eisen H, Ross H (2004) Optimizing the immunosuppressive regimen in heart transplantation. J Heart Lung Transplant 23:S207–213Google Scholar
  12. Englesbe MJ, Wu AH, Clowes AW, Zierler RE (2003) The prevalence and natural history of aortic aneurysms in heart and abdominal organ transplant patients. J Vasc Surg 37:27–31PubMedGoogle Scholar
  13. Fishman JA, Rubin RH (1998) Infection in organ —transplant recipients. N Engl J Med 338:1741–1751PubMedGoogle Scholar
  14. Goldstein DJ, Austin JHM, Zuech N et al (1996) Carcinoma of the lung after heart transplantation. Transplantation 62:772–775PubMedGoogle Scholar
  15. Haldas J, Wang W, Lazarchick J (2002) Post-transplant lymphoproliferative disorders: T-cell lymphoma following cardiac transplant. Leukemia Lymphoma 43(2):447–450PubMedGoogle Scholar
  16. Haramati LB, Schulman LL, Austin JHM (1993) Lung nodules and masses after cardiac transplantation. Radiology 188:491–497PubMedGoogle Scholar
  17. Henry DA, Corcoran HL, Lewis TD et al (1989) Orthotopic cardiac transplantation: evaluation with CT. Radiology 170:343–350PubMedGoogle Scholar
  18. Higgins CD, Swerdlow AJ, Smith JD, Hunt BJ, Thomas JA, Burke MM, Crawford DH, Yacoub MH (2003) Risk of lymphoid neoplasia after cardiothoracic transplantation: the influence of underlying disease and human leukocyte antigen type and matching. Transplantation 75:1698–1703PubMedGoogle Scholar
  19. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Novick RJ (1997) The registry of the International Society for Heart and Lung Transplantation: fourteenth official report-1997. J Heart Lung Transplant 16:691–712PubMedGoogle Scholar
  20. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ (1999) The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report —1999. J Heart Lung Transplant 18:611–626PubMedGoogle Scholar
  21. Johnson WM, Baldursson O, Gross TJ (1998) Double jeopardy: lung cancer after transplantation. Chest 113:1720–1723PubMedGoogle Scholar
  22. Jolies H, Henry DA, Roberson JP, Cole TJ, Spratt JA (1996) Mediastinitis following median sternotomy: CT findings. Radiology 201:463–466Google Scholar
  23. Kirklin JK, McGiffin DC, Pinderski LJ, Tallaj J (2004) Selection of patients and techniques of heart transplantation. Surg Clin N Am 84:257–287PubMedGoogle Scholar
  24. Knisely BL, Mastey LA, Collins J, Kuhlman JE (1999) Imaging of cardiac transplantation complications. Radio-Graphics 19:321–339Google Scholar
  25. Knollmann FD, Hummel M, Hetzer R, Felix R (2000a) CT of heart transplant recipients: spectrum of disease. Radio-Graphics 20:1637–1648Google Scholar
  26. Knollmann FD, Bocksch W, Spiegelsberger S, Hetzer R, Felix R, Hummel M (2000b) Electron-beam computed tomography in the assessment of coronary artery disease after heart transplantation. Circulation 101:2078–2082PubMedGoogle Scholar
  27. Knosalla C, Weng Y, Warnecke H et al (1996) Mycotic aortic aneurysms after orthotopic heart transplantation. J Heart Lung Transplant 15:827–839PubMedGoogle Scholar
  28. Kobashigawa JA, Kirklin JK, Naftel DC et al (1993) The Transplant Cardiologists Research Database Group: pretransplantation risk factors for acute rejection after heart transplantation a multi-institutional study. J Heart Lung Transplant 12:355–366PubMedGoogle Scholar
  29. Kuhlman JE (2002) Thoracic imaging in heart transplantation. J Thoracic Imag 17:113–121Google Scholar
  30. Kuhlman JE (2004) The immunocompromised host: chest. In: Husband JE, Reznek RH (eds) Imaging in oncology, 2nd edn, chap 58. Taylor and Francis, London, pp 1337–1362Google Scholar
  31. Kwak EJ, Strollo DC, Kulich SM, Kusne S (2003) Cavitary pneumonia due to Rhodococcus equi in a heart transplant recipient. Transplant Infect Dis 5:43–46Google Scholar
  32. Lazem F, Barbir M, Banner N, Ludman P, Mitchell A, Yacoub M (1997) Coronary calcification detected by ultrafast computed tomography is a predictor of cardiac events in heart transplant recipients. Transplant Proc 29:572–575PubMedGoogle Scholar
  33. Leung AN (1999) Invited Commentary: Scientific exhibit. RadioGraphics 19(2):340–341Google Scholar
  34. Levin T, Suh B, Beltramo D, Samuel R (2004) Aspergillus mediastinitis following orthotopic heart transplantation: case report and review of the literature. Transplant Infectious Disease 6:129–131PubMedGoogle Scholar
  35. Massad MG (2004) Current trends in heart transplantation. Cardiology 101:79–92PubMedGoogle Scholar
  36. Miller LW, Schlant RC, Kobashigawa R, Kubo S, Renlund DG (1993) 24th Bethesda conference: cardiac transplantation. Task force 5: complications. J Am Coll Cardiol 22:41–54Google Scholar
  37. O’Neill JO, Taylor DO, Starling RC (2004) Immunosuppression for cardiac transplantation. The past, present, and future. Transplant Proc 36[Suppl 2S]:309S–313SPubMedGoogle Scholar
  38. Penn I (1979) Tumor incidence in human allograft recipients. Transplant Proc 11:1047–1051PubMedGoogle Scholar
  39. Petri WA Jr (1994) Infections in heart transplant recipients. Clin Infect Dis 18:141–148PubMedGoogle Scholar
  40. Pham SM, Kormos RL, Landreneau RJ et al (1995) Solid tumors after heart transplantation: lethality of lung cancer. Ann Thorac Surg 60:1623–1626PubMedGoogle Scholar
  41. Poston RS, Griffith BP (2004) Heart transplantation. J Intensive Care Med 19(1):3–12PubMedGoogle Scholar
  42. Potaris K, Radovancevic B, Thomas CD, Gregoric I, Vaporciyan AA, Riggs SA, Radovancevic R, Vaugh WK, Frazier OH (2005) Lung cancer after heart transplantation: 17-year experience. Ann Thoracic Surg 79:980–983Google Scholar
  43. Reitz BA, Fowles RE, Ream AK (1982) Cardiac transplantation. In: Ream AK, Fogdall RP (eds) Acute cardiovascular management, anesthesia, and intensive care. Lippincott, Philadelphia, Pa., pp 549–567Google Scholar
  44. Rodeheffer RJ, McGregor CGA (1992) The development of cardiac transplantation. Mayo Clin Proc 67:480–484PubMedGoogle Scholar
  45. Rubin RH (2000) Prevention and treatment of cytomegalovirus disease in heart transplant patients. J Heart Lung Transplant 19:731–735PubMedGoogle Scholar
  46. Schellemans C, Tack W, Vanderheyden M (2004) Acute type A aortic dissection in a cardiac allographt recipient: case report and review of the literature. Heart 90:1256–1258PubMedGoogle Scholar
  47. Shanewise J (2004) Cardiac transplantation. Anesthesiology Clin N Am 22:753–765Google Scholar
  48. Shiba N, Chan MCY, Kwok BW, Valantine HA, Robbins RC, Hunt SA (2004) Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience. J Heart Lung Transplant 23(2):155–164PubMedGoogle Scholar
  49. Shirazi KK, Amendola MA, Tisnado J et al (1983) Radiographic findings in the chest of patients following cardiac transplantation. Cardiovasc Intervent 6:1–6Google Scholar
  50. St Goar FG, Pinto FJ, Alderman EL et al (1992) Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of“angiographically silent”intimai thickening. Circulation 85:979–987Google Scholar
  51. Taylor DOES, Edwards LB, Boucek MM, Trulock EP, Keck BM, Hertz MI (2004) The registry of the international society for heart and lung transplantation: twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 23(7):796–803PubMedGoogle Scholar
  52. Thaler SJ, Rubin RH (1996) Opportunistic infections in the cardiac transplant recipient. Curr Opin Cardiol 11:191–203PubMedGoogle Scholar
  53. Thorsen MK, Goodman LR (1988) Extracardiac complications of cardiac surgery. Semin Roentgenol 23:32–48PubMedGoogle Scholar
  54. Valantine H (2004) Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant 23:S187–S193PubMedGoogle Scholar
  55. Winkel E, DiSesa VJ, Costanzo MR (1999) Advances in heart transplantation. Dis Mon 45(3):62–87PubMedGoogle Scholar
  56. Yamani MH, Starling RC (2000) Long-term medical complications of heart transplantation: information for the primary care physician. Cleveland Clinic J Med 67:673–680Google Scholar
  57. Young L, Alfieri C, Hennessy K et al (1989) Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080–1085PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • Herwig Antretter
    • 1
  • Guenther Laufer
    • 1
  • Janet E. Kuhlman
    • 2
  1. 1.Klinische Abteilung für HerzchirurgieUniversitätsklinik für ChirurgieAustria
  2. 2.Department of Radiology, Thoracic Imaging SectionUniversity of Wisconsin Medical SchoolMadisonUSA

Personalised recommendations